Hidradenitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
Condition:   Hidradenitis Suppurativa Interventions:   Drug: Deucravacitinib;   Drug: Placebo Sponsors:   Beth Israel Deaconess Medical Center;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials

HIDRAdenitis Suppurativa and HEART Disease
Conditions:   Hidradenitis;   Hidradenitis Suppurativa;   Hidradenitis Suppurativa, Familial;   Left Ventricular Dysfunction;   Myocardial Infarction;   Myocardial Ischemia;   Heart Failure;   Stroke;   Heart Diseases;   Heart Failure, Systolic;   Heart Failure, Diastolic Intervention:   Sponsor:   Herlev and Gentofte Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials